<img alt="" height="1" width="1" />
Novartis drug may help older breast cancer patients
STOCKHOLM (Reuters) - Novartis&#39;s bone drug Zometa extended survival in older breast cancer patients but failed to improve disease-free survival among younger women patients in a large-scale clinical trial, researchers said on Sunday. ...
Novartis&#39;s Zometa Fights Breast Cancer in Post-Menopausal WomenBloomberg
Breast cancer tumor make-up changes through the course of diseaseEurekAlert (press release)
CANCER DRUG IS &#39;HOLY GRAIL&#39;Express.co.uk

all 14 news articles &raquo;